Latest News Archive

Please select Category, Year, and then Month to display items
Years
2019 2020 2021 2024
Previous Archive
11 October 2019 | Story Leonie Bolleurs | Photo Supplied
Staff and Students from the Department of Physics
Staff and students from the UFS Department of Physics with parts of the newly arrived astronomical spectrograph for the Boyden Observatory 1,5-m telescope. From the left, are: Dr Pat van Heerden, Daniel Kulik (honours student), Joleen Els (third-year student), Justin Cooper (honours student), Helene Szegedi (lecturer), Professor Petrus Meintjes, Dr Brian van Soelen, and Dr Richard Gray.

Stable atmospheric environments and near perfect weather conditions were the main reasons for the establishment of the Boyden Observatory a few kilometres outside Bloemfontein. This astronomical research observatory and science education centre is managed by the Department of Physics at the University of the Free State (UFS).

With the newly acquired astronomical spectrograph for the Boyden Observatory 1,5-m telescope, scientists will be able to gain visual access to both the Northern and Southern Hemisphere skies.

Collaboration with expert in stellar spectroscopy 


The spectrograph, mainly developed and built by Dr Richard Gray, will be used collaboratively for astronomical research by the UFS and the Appalachian State University (ASU) in North Carolina, where Dr Gray is based. 

Dr Gray is a world-renowned expert in stellar spectroscopy and leading author of one of the most influential textbooks on stellar spectroscopy, Stellar Spectral Classification, with co-author Christopher J Corbally.

Dr Gray recently received a Fulbright Scholarship from the Fulbright Foundation to spend a full year in the UFS Department of Physics, where he will lecture several Astronomy classes and do research in collaboration with personnel of the UFS Astrophysics Research Group. He will also lead the assembly of the instrument over the next few weeks, working with personnel and students in the Department of Physics as well as the UFS Instrumentation Division.

According to Prof Pieter Meintjes, Senior Professor from the UFS Department of Physics, some components of the instrument have been developed and constructed by the university’s Instrumentation Division, with key components purchased from funding by the Directorate: Research Development at the UFS.

Unique capability in infrastructure 

“The availability of a sophisticated instrument of this nature on the 1,5-m telescope will place the UFS Astrophysics Group in an elite bracket in terms of the available infrastructure for astronomical research,” said Prof Meintjes.

He explained: “The combined polarimetric-spectroscopic capability in one single instrument is unique. Combined with the fact that it is hosted on a research instrument that is utilised and maintained exclusively by the UFS Astronomy Group in the Department of Physics, gives this group a competitive edge in relation to most international astronomy groups.” 

The instrument is valued at close to R1,5 million. 

The Boyden Observatory
The Boyden Observatory. (Photo:Supplied)

According to Prof Meintjes, the instrument will be mounted at the backend of the UFS Boyden 1,5-m telescope and will allow them to do simultaneous polarimetry and spectroscopy of astronomical sources. “This is vital for the research we are working on,” he said.

International collaboration and student development

The instrument also brings with it the possibility of forging international collaborations for research as well as student development. “This can advance the stature of the UFS as an internationally respected research-led tertiary institution,” said Prof Meintjes. 

The possibility of making the UFS Boyden 1,5-m telescope completely remote-controlled, is being investigated. “This will serve the observational needs of researchers from both the UFS and the ASU, with researchers at ASU able to access the telescope for their own in-house research programmes. The availability of such an instrument on the UFS 1,5-m telescope also opens up the possibility to accommodate visiting researchers from ASU or elsewhere in the world at Boyden,” said Prof Meintjes.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept